Fig. 1From: Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathwayProtein levels of SIRT-1, PPAR- γ (a), TLR-4, Cyclin D-1 (b) in diabetic pediatrics with/without lactofrrin treatment, compared to the control cohorts. *Significant difference from control group at P < 0.05. ΨSignificant difference from Lf/insulin group at P < 0.05Back to article page